MALVERN, PA — In recognition of Suicide Prevention Month, Neuronetics, Inc. (NASDAQ: STIM) is spotlighting the impactful stories shared on its NeuroStar Voices Portal. This platform, launched last year, allows individuals to recount their journeys of overcoming depression with the help of NeuroStar Advanced Therapy. As part of its mission, NeuroStar is striving to save 3,325 lives through this transformative therapy and has now reached the halfway point of this ambitious goal.
Since its inception, NeuroStar has treated 88,533 patients, potentially saving 1,771 lives. This achievement is significant within the framework of a five-year plan to treat 166,240 individuals. The initiative builds upon the momentum gained since NeuroStar first received FDA clearance in 2008. The swift treatment of over 88,000 patients in recent years highlights the growing impact of this therapy.
Keith J. Sullivan, President and CEO of Neuronetics, Inc., highlighted the emotional significance of these milestones: “When we set the goal of saving 3,325 lives, it was more than an objective—it was a heartfelt commitment to providing hope to those struggling to stay afloat. Surpassing the halfway mark underscores that every life saved is a testament to the bravery of those fighting depression and the impact NeuroStar has on their mental health journey.”
The NeuroStar Voices Portal highlights the therapy’s life-saving impact with personal testimonials:
- Kayla from Arkansas shared, “My life has completely changed since NeuroStar TMS. I tell everybody all the time that it did not just change my life, but it saved my life.”
- Curry from Massachusetts expressed, “NeuroStar TMS was probably the best thing that could have happened. I feel so much freer without that heaviness of depression. There’s light now.”
- Kat from Ohio emphasized, “I want people with depression to know that THEY are worth the time commitment, the effort, and the healing NeuroStar TMS will bring to get them back to a productive, happy, enjoyable life!”
This comes amid a backdrop of rising suicide rates in the U.S., with nearly 50,000 Americans dying by suicide in 2022 according to the CDC. These statistics spotlight the urgent need for effective mental health treatments like NeuroStar, which offers a beacon of hope and support to those in need. Through continued innovation and commitment, Neuronetics, Inc. aims to make a profound difference in mental health care.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.